Real-world data demonstrate that nirsevimab and maternal vaccination protect infants against severe RSV outcomes.

The age-adjusted suicide rate increased from 2014 to 2017 and then did not change significantly from 2017 through 2024.

MenB coverage was improved but still suboptimal among individuals aged 10 to 25 years who had high-risk conditions, with an overall initiation rate of 39%. Patients with asplenia were most likely to ...

Updated BNT162b2 KP.2 vaccination reduces COVID-19 hospitalizations and ED visits in immunocompetent adults regardless of risk status.

Data presented at USCHA 2026 demonstrate that culturally-responsive campaigns significantly improve HIV PrEP awareness.

A large-scale testing initiative identified patients in the Puerto Rican correctional system with positive results for HIV ...

Infectious Disease Advisor provides news updates and key opinion leader interviews from USCHA 2026, held in Anaheim, ...

Disparities in pre-exposure prophylaxis access and routine screening continue to hinder national efforts to prevent and treat ...

Integrating community pharmacies into the HIV prevention landscape offers accessible, disease-agnostic entry points for PrEP ...

A mobile retail pharmacy and clinic model in Connecticut improves HIV care and substance use treatment for vulnerable ...

Previous STI history is linked to increased current PrEP use, though uptake disparities remain across patient demographic ...

Women living with HIV experience disproportionate clinical disparities and remain underrepresented in research and clinical ...